|
Apr 28
|
Pfizer’s sasanlimab and BCG combo therapy improves EFS in bladder cancer trial
|
|
Apr 28
|
My 5 Top Stocks to Buy Right Now in This Highly Volatile Market
|
|
Apr 28
|
Pfizer (PFE) Reports Q1: Everything You Need To Know Ahead Of Earnings
|
|
Apr 27
|
Pfizer Inc. (PFE): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential
|
|
Apr 27
|
1 Stock to Buy, 1 Stock to Sell This Week: Meta Platforms, Pfizer
|
|
Apr 26
|
Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer
|
|
Apr 25
|
Investing Action Plan: Apple, Amazon, Pfizer, Caterpillar And Sparring With The Fed
|
|
Apr 25
|
Biohaven stock slides on withdrawal of European marketing application
|
|
Apr 25
|
Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season?
|
|
Apr 25
|
Stocks to watch this week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca
|
|
Apr 24
|
Guardant Health, Pfizer Collaborate To Develop New Cancer Therapies Using Liquid Biopsy Platform
|
|
Apr 24
|
Pfizer (NYSE:PFE) Collaborates With Guardant Health on Oncology; Declares US$0.43 Dividend
|
|
Apr 24
|
PFE vs. LLY: Which Stock Should Value Investors Buy Now?
|
|
Apr 24
|
Eli Lilly (LLY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
|
Apr 18
|
Pfizer Abandons Its Leading Weight Loss Candidate. Should You Sell the Stock?
|
|
Apr 18
|
3 Magnificent S&P 500 Dividend Stocks Down 11% to 63% to Buy and Hold Forever
|
|
Apr 18
|
Why Eli Lilly and Company (LLY) is Skyrocketing?
|
|
Apr 17
|
Pfizer (PFE) Laps the Stock Market: Here's Why
|
|
Apr 17
|
US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years
|
|
Apr 17
|
Is Pfizer Inc. (PFE) the Best Large-Cap Value Stock to Buy as the Recession Hits?
|